Community pharmacy’s representative bodies are demanding greater clarity on the Health and Care Bill set out in today’s speech.

New guidance clarifies the obligations on suppliers in Regulation 28 and 29 of the Health Service Products Regulations 2018.

There has been a lower than expected level of disruption to the medicines supply chain since the end of the withdrawal period on January 1 says DHSC.

New body will lead national efforts to tackle obesity, improve mental health and promote physical activity.

The Department for Health and Social Care has issued a serious shortage protocol for anti-diabetes medicine Competact with immediate effect

SSPs for Fluoxetine 30mg capsules and Levothyroxine 12.5mcg tablets have been extended.

The serious shortage protocol for Levothyroxine 12.5mcg tablets has been extended by the DHSC.

Repaglinide 1mg and 2mg tablets will be out of stock until early May.

The serious shortage protocol for Salazopyrin EN-Tabs 500mg has been extended until March 8.

Pharmacy technicians and dispensing staff have been invited to join a panel that assesses the quality of PPE.

The Government hopes additional supplies will boost the largest ever flu vaccination programme in 2020-21.

Treasury's refusal to offer contractors more cash is 'not in line with ministers' promises' says PSNC chief Simon Dukes. 

Pharmacies can deliver flu vaccines using the DHSC's centrally procured stock from tomorrow.

The DHSC has today announced the second wave of price concessions for December.

A petition urging the government to cover costs incurred by pharmacies during Covid-19 is gathering pace.

The PSNC is seeking urgent clarity from NHS England & Improvement on the opening requirements for pharmacies over the Christmas period.

The DHSC has today announded the second wave of price concessions for November.

DHSC will advise which wholesalers have been allocated stock via the NHSBSA website.

The Department of Health and Social Care has today announced the first wave of concessions for November.

The PSNC has issued a clarification concerning comments made by a Department of Health spokesperson on Covid-19 funding for pharmacies.